Literature DB >> 33569635

Microbial-derived antigens and metabolites in spondyloarthritis.

Katharine Lu Yang1, Alannah Lejeune1, Gregory Chang2, Jose U Scher3,4, Sergei B Koralov5.   

Abstract

Spondyloarthritis (SpA) is a group of chronic, immune-mediated, inflammatory diseases affecting the bone, synovium, and enthesis. Microbiome, the community of microorganisms that has co-evolved with human hosts, plays a pivotal role in human health and disease. This invisible "essential organ" supplies the host with a myriad of chemicals and molecules. In turn, microbial metabolites can serve as messengers for microbes to communicate with each other and in the cross-talk with host cells. Gut dysbiosis in SpA is associated with altered microbial metabolites, and an accumulated body of research has contributed to the understanding that changes in intestinal microbiota can modulate disease pathogenesis. We review the novel findings from human and animal studies to provide an overview of the contribution of individual microbial metabolites and antigens to SpA.

Entities:  

Keywords:  Ankylosing spondylitis; MCFA; Metabolite; Microbial metabolite; Microbial trigger; Microbiota; Polyamine; Psoriatic arthritis; SCFA; Short chain fatty acid; SpA; Spondyloarthritis; Th17; Trimethylamine; Tryptophan

Mesh:

Year:  2021        PMID: 33569635     DOI: 10.1007/s00281-021-00844-1

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   11.759


  78 in total

Review 1.  Review: The interleukin-23/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyond.

Authors:  Judith A Smith; Robert A Colbert
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

2.  Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.

Authors:  Jose U Scher; Carles Ubeda; Alejandro Artacho; Mukundan Attur; Sandrine Isaac; Soumya M Reddy; Shoshana Marmon; Andrea Neimann; Samuel Brusca; Tejas Patel; Julia Manasson; Eric G Pamer; Dan R Littman; Steven B Abramson
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

Review 3.  One year in review 2017: spondyloarthritis.

Authors:  Riccardo Terenzi; Sara Monti; Giulia Tesei; Linda Carli
Journal:  Clin Exp Rheumatol       Date:  2018-02-05       Impact factor: 4.473

Review 4.  The human-microbiome superorganism and its modulation to restore health.

Authors:  E Salvucci
Journal:  Int J Food Sci Nutr       Date:  2019-03-07       Impact factor: 3.833

5.  Gut Microbiota Perturbations in Reactive Arthritis and Postinfectious Spondyloarthritis.

Authors:  Julia Manasson; Nan Shen; Helga R Garcia Ferrer; Carles Ubeda; Isa Iraheta; Adriana Heguy; Joan M Von Feldt; Luis R Espinoza; Abraham Garcia Kutzbach; Leopoldo N Segal; Alexis Ogdie; Jose C Clemente; Jose U Scher
Journal:  Arthritis Rheumatol       Date:  2018-01-03       Impact factor: 10.995

Review 6.  Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment.

Authors:  George E Fragoulis; Christina Liava; Dimitrios Daoussis; Euangelos Akriviadis; Alexandros Garyfallos; Theodoros Dimitroulas
Journal:  World J Gastroenterol       Date:  2019-05-14       Impact factor: 5.742

7.  Altered Bacterial-Fungal Interkingdom Networks in the Guts of Ankylosing Spondylitis Patients.

Authors:  Ming Li; Bingbing Dai; Yawei Tang; Lei Lei; Ningning Li; Chang Liu; Teng Ge; Lilong Zhang; Yao Xu; Yuqi Hu; Pengfei Li; Yan Zhang; Jieli Yuan; Xia Li
Journal:  mSystems       Date:  2019-03-26       Impact factor: 6.496

8.  A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin.

Authors:  Eva Klingberg; Maria K Magnusson; Hans Strid; Anna Deminger; Arne Ståhl; Johanna Sundin; Magnus Simrén; Hans Carlsten; Lena Öhman; Helena Forsblad-d'Elia
Journal:  Arthritis Res Ther       Date:  2019-11-27       Impact factor: 5.156

9.  Defining Dysbiosis for a Cluster of Chronic Diseases.

Authors:  Lamont J Wilkins; Manoj Monga; Aaron W Miller
Journal:  Sci Rep       Date:  2019-09-09       Impact factor: 4.379

10.  Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation?

Authors:  Stefan Siebert; Neal L Millar; Iain B McInnes
Journal:  Ann Rheum Dis       Date:  2018-10-08       Impact factor: 19.103

View more
  3 in total

Review 1.  The Potential Role of Genetics, Environmental Factors, and Gut Dysbiosis in the Aberrant Non-Coding RNA Expression to Mediate Inflammation and Osteoclastogenic/Osteogenic Differentiation in Ankylosing Spondylitis.

Authors:  Hsien-Tzung Liao; Chang-Youh Tsai; Chien-Chih Lai; Song-Chou Hsieh; Yi-Syuan Sun; Ko-Jen Li; Chieh-Yu Shen; Cheng-Han Wu; Cheng-Hsun Lu; Yu-Min Kuo; Tzu-Hao Li; Chung-Tei Chou; Chia-Li Yu
Journal:  Front Cell Dev Biol       Date:  2022-01-20

Review 2.  The Pathology and Physiology of Ileostomy.

Authors:  Haitao Ma; Xiaolong Li; Hua Yang; Yuan Qiu; Weidong Xiao
Journal:  Front Nutr       Date:  2022-04-22

Review 3.  The Interaction among Microbiota, Epigenetic Regulation, and Air Pollutants in Disease Prevention.

Authors:  Alessandra Pulliero; Deborah Traversi; Elena Franchitti; Martina Barchitta; Alberto Izzotti; Antonella Agodi
Journal:  J Pers Med       Date:  2021-12-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.